openPR Logo
Press release

Soliris Drug Market: An In-Depth Analysis

03-05-2025 09:58 AM CET | Health & Medicine

Press release from: orion market research

Soliris drug market

Soliris drug market

The market size for Soliris (eculizumab) was estimated at approximately USD 4.2 billion in 2023 and is projected to reach around USD 9.7 billion by 2032, indicating a compound annual growth rate (CAGR) of 9.7% from 2024 to 2032.

Soliris Drug Market Overview

The Soliris (eculizumab) drug market plays a crucial role in the treatment of rare and life-threatening diseases, including paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and generalized myasthenia gravis (gMG). As a high-cost monoclonal antibody therapy, Soliris has seen strong market demand due to its effectiveness in managing these conditions. The market is primarily driven by increasing awareness, rising prevalence of rare diseases, and advancements in biotechnology. However, the entry of biosimilars and the development of next-generation complement inhibitors, such as Ultomiris (ravulizumab), are impacting market dynamics. North America and Europe dominate the market due to strong healthcare infrastructure and reimbursement policies, while Asia-Pacific is emerging as a growth region. Despite competitive pressures, Soliris remains a key player in the rare disease drug market, with sustained demand in critical care settings.

Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-drug-market

Advantages of requesting a Sample Copy of the Report:
1) To understand how our report can bring a difference to your business strategy
2) To understand the analysis and growth rate in your region
3) Graphical introduction of global as well as the regional analysis
4) Know the top key players in the market with their revenue analysis
5) SWOT analysis, PEST analysis, and Porter's five force analysis

The report further explores the key business players along with their in-depth profiling
Alexion Pharmaceuticals, AstraZeneca and more.....

Soliris Drug Market Segments:
◘ By Type: Eculizumab, Complement Inhibition
◘ By Application: Rare Diseases, Hematology, Nephrology

Report Drivers & Trends Analysis:
The report also discusses the factors driving and restraining market growth, as well as their specific impact on demand over the forecast period. Also highlighted in this report are growth factors, developments, trends, challenges, limitations, and growth opportunities. This section highlights emerging Soliris Drug Market trends and changing dynamics. Furthermore, the study provides a forward-looking perspective on various factors that are expected to boost the market's overall growth.

Competitive Landscape Analysis:
In any market research analysis, the main field is competition. This section of the report provides a competitive scenario and portfolio of the Soliris Drug Market's key players. Major and emerging market players are closely examined in terms of market share, gross margin, product portfolio, production, revenue, sales growth, and other significant factors. Furthermore, this information will assist players in studying critical strategies employed by market leaders in order to plan counterstrategies to gain a competitive advantage in the market.

Regional Outlook:
The following section of the report offers valuable insights into different regions and the key players operating within each of them. To assess the growth of a specific region or country, economic, social, environmental, technological, and political factors have been carefully considered. The section also provides readers with revenue and sales data for each region and country, gathered through comprehensive research. This information is intended to assist readers in determining the potential value of an investment in a particular region.

» North America (U.S., Canada, Mexico)
» Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
» Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
» South America (Brazil, Argentina, Rest of SA)
» Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)

If you have any special requirements, Request customization: https://www.omrglobal.com/report-customization/soliris-drug-market

Soliris Drug Benefits for Stakeholders:
⏩ The study represents a quantitative analysis of the present Soliris Drug Market trends, estimations, and dynamics of the market size from 2025 to 2032 to determine the most promising opportunities.
⏩ Porter's five forces study emphasizes the importance of buyers and suppliers in assisting stakeholders to make profitable business decisions and expand their supplier-buyer network.
⏩ In-depth analysis, as well as the market size and segmentation, help you identify current Soliris Drug Market opportunities.
⏩ The largest countries in each region are mapped according to their revenue contribution to the market.
⏩ The Soliris Drug Market research report gives a thorough analysis of the current status of the Soliris Drug Market's major players.

Soliris Drug questions answered in the report:
➧ What will the market development pace of the Soliris Drug Market?
➧ What are the key factors driving the Soliris Drug Market?
➧ Who are the key manufacturers in the market space?
➧ What are the market openings, market hazards,s and market outline of the Soliris Drug Market?
➧ What are the sales, revenue, and price analysis of the top manufacturers of the Soliris Drug Market?
➧ Who are the distributors, traders, and dealers of Soliris Drug Market?
➧ What are the market opportunities and threats faced by the vendors in the Soliris Drug Market?
➧ What are deals, income, and value examination by types and utilizations of the Soliris Drug Market?
➧ What are deals, income, and value examination by areas of enterprises in the Soliris Drug Market?

Purchase Now Up to 25% Discount on This Premium Report: https://www.omrglobal.com/buy-now/soliris-drug-market?license_type=license-single-user

Reasons To Buy The Soliris Drug Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods

Contact Us:
Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Website: www.omrglobal.com
Follow Us: LinkedIn | Twitter

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Soliris Drug Market: An In-Depth Analysis here

News-ID: 3898606 • Views:

More Releases from orion market research

Algorithmic Trading Market Size Future Scope, Demands and Projected Industry Growths to 2033
Algorithmic Trading Market Size Future Scope, Demands and Projected Industry Gro …
The global algorithmic trading market was valued at approximately USD 13.05 billion in 2023 and is projected to reach about USD 35.45 billion by 2033, reflecting an anticipated compound annual growth rate (CAGR) of 10.51 percent between 2024 and 2033. Algorithmic Trading Market Overview The global algorithmic trading market is experiencing robust growth due to the increasing adoption of advanced technologies such as artificial intelligence and machine learning in financial services. These
IoT in Construction Market Rising Demand and Growth Forecast Through 2033
IoT in Construction Market Rising Demand and Growth Forecast Through 2033
The global IoT in Construction market was valued at USD 12.2 billion in 2024 and is projected to reach USD 31.3 billion by 2033, reflecting a robust CAGR of approximately 10.5% for the period of 2025-2033. IoT in Construction Market Overview In 2024, the IoT in Construction market stood at about USD 12.2 billion, driven by rising demand for real-time asset monitoring, enhanced safety protocols, and smarter operational workflows on
Tourism Vehicle Rental Market Rising Demand and Growth Forecast Through 2033
Tourism Vehicle Rental Market Rising Demand and Growth Forecast Through 2033
The global tourism vehicle rental market was valued at USD 59.7 billion in 2024 and is expected to reach approximately USD 98.0 billion by 2033, growing at a CAGR of about 5.66% from 2025 to 2033. Tourism Vehicle Rental Market Overview In 2024, the global Tourism Vehicle Rental Market stood at around USD 59.7 billion, driven by the steady rise in global travel, growing demand for flexible transportation, and the adoption
Food Hydrocolloids Market Size, Shares, Business Growth and Upcoming Trends Forecast by 2033
Food Hydrocolloids Market Size, Shares, Business Growth and Upcoming Trends Fore …
The global Food Hydrocolloids Market size was valued at USD 12.4 billion in 2024 and is anticipated to reach USD 19.6 billion by 2033, growing at a CAGR of 5.2% from 2025 to 2033. Food Hydrocolloids Market Overview The Food Hydrocolloids Market is experiencing steady growth, driven by the increasing demand for natural and functional ingredients in food and beverages. Hydrocolloids, such as gelatin, pectin, carrageenan, xanthan gum, and guar gum, are

All 5 Releases


More Releases for Soliris

Global Soliris Market Outlook 2025-2034: Trends, Innovations, And Future Outlook
The Soliris Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Soliris Market Size and Projected Growth Rate? In recent times, the Soliris market has experienced significant growth. The market, which stood at $1,880.37 million in 2024, is anticipated to increase to $2,030.44 million
Future Outlook of the Soliris Intravenous Market: Soliris Intravenous Trends and …
The global Soliris Intravenous Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 6.8 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-intravenous-market Soliris Intravenous Market Overview: The Soliris Intravenous Market is experiencing steady growth driven by the increasing prevalence of rare and chronic diseases such as
Global Soliris Intravenous Market Future Prediction Report By 2032
The global Soliris intravenous market was valued at approximately USD 4.23 billion in 2023 and is projected to reach around USD 7.12 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2032. Global Soliris Intravenous Market Overview Soliris (eculizumab) is a monoclonal antibody developed by Alexion Pharmaceuticals to treat rare, life-threatening diseases such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and
Growing Prevalence Of Rare Blood Disorders To Drive Soliris Market Expansion: Ma …
How Will the Soliris Market Grow, and What Is the Projected Market Size? The market size of Soliris has experienced significant growth in the past few years. Its expansion from $1,880.37 million in 2024 to $2,030.44 million in 2025 represents a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the historic period include regulatory approvals, increased awareness of rare diseases, a rising demand for complement inhibition,
Soliris Market Size, Growing Demand to 2033 Alexion
Soliris (eculizumab) is a groundbreaking monoclonal antibody used to treat rare, life-threatening diseases like paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and generalized myasthenia gravis (gMG). It works by inhibiting the complement system, a part of the immune response that can attack healthy cells when overactivated. Approved by the FDA in 2007, Soliris was one of the most expensive drugs globally, reflecting its role in addressing ultra-rare conditions.
Soliris Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the Soliris market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Solirismarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of Solirismarket, market definition, overview, industry opportunities and trends, investment strategy with forceful